ReviewAPL bioengineering2026
Biomolecular and cellular chirality: Novel diagnostic perspectives for diseases.
Review in APL bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chirality is an intrinsic characteristic of living systems, manifesting as a pervasive asymmetry from the molecular to the cellular level. This asymmetry regulates normal life activities through precise stereospecific recognition between molecules and between molecules and cells. Under physiological conditions, L-amino acids constitute proteins that support metabolic functions, right-handed helical deoxyribonucleic acid (DNA) stores genetic information, and right-handed sugars provide energy. At the cellular level, the non-centrosymmetric arrangement of the cytoskeleton guides the left-right axial positioning during embryonic development and organ formation. A certain degree of chiral inversion occurs under normal physiological conditions-for instance, trace amounts of D-amino acids modulate neurotransmitter release, and low level of left-handed DNA promotes double-strand unwinding, facilitating transcription. However, excessive accumulation of D-amino acids is closely associated with Alzheimer's disease, chronic kidney di'ease, diabetes, and aging. Similarly, the presence of substantial left-handed DNA fragments can lead to genomic instability, "increasin" sus'eptibility to tumorigenesis. Moreover, abnormalities in cellular chirality may contribute to vascular endothelial barrier disruption and improper left-right organ positioning. Therefore, monitoring aberrant chiral molecules and cells that deviate from the normal range holds promise for the early diagnosis of diseases such as nephropathy, Alzheimer's disease, diabetes, and cancer. This article primarily reviews the dynamic chiral balance under physiological and pathological conditions, providing a reference for the application of chirally inverted molecules and cells Is potential novel biomarkers for the early diagnosis of diseases.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.